Open access
Open access
Powered by Google Translator Translator

Dermatology

Dermatologic immune-related adverse events: the toxicity spectrum and recommendations for management.

19 Jan, 2022 | 08:15h | UTC

Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management – International Journal of Women’s Dermatology

Related: Management of Dermatologic Adverse Events from Cancer Therapies

 


Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.

18 Jan, 2022 | 09:23h | UTC

Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide – American Journal of Clinical Dermatology

 


Phase 2 RCT: In patients with generalized pustular psoriasis, Spesolimab improved lesions at one week but was associated with infections and systemic drug reactions.

14 Jan, 2022 | 08:01h | UTC

Trial of Spesolimab for Generalized Pustular Psoriasis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Trial of Spesolimab for Generalized Pustular Psoriasis – Mount Sinai

 


RCT: In patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) treated with Infliximab, a proactive therapeutic drug monitoring protocol was more likely to lead to sustained disease control.

14 Jan, 2022 | 07:57h | UTC

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Review: Diagnosis and treatment of sexually transmitted infections.

13 Jan, 2022 | 08:38h | UTC

Diagnosis and Treatment of Sexually Transmitted Infections: A Review – JAMA (free for a limited period)

 


RCT: In patients with untreated advanced melanoma, treatment with Relatlimab plus Nivolumab was associated with increased median progression-free survival compared with Nivolumab alone (10.1 months vs. 4.6 months).

12 Jan, 2022 | 08:43h | UTC

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma – University of Texas M. D. Anderson Cancer Center

 

Commentary on Twitter

 


Phase 3 trials of Tapinarof cream for plaque psoriasis.

16 Dec, 2021 | 08:49h | UTC

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis – New England Journal of Medicine

Commentary: Topical tapinarof reduces severity of plaque psoriasis – HealthDay

 

Commentary on Twitter

 


Short Review: Lymphogranuloma venereum.

14 Dec, 2021 | 08:42h | UTC

Lymphogranuloma venereum – Canadian Medical Association Journal

 


RCT: Long-term outcomes with Nivolumab plus Ipilimumab or Nivolumab alone vs. Ipilimumab in patients with advanced melanoma.

5 Dec, 2021 | 23:07h | UTC

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma – Journal of Clinical Oncology

Editorial: CheckMate-067: Raising the Bar for the Next Decade in Oncology – Journal of Clinical Oncology

Original Study: #ESMO19 – Randomized Trial: Improved Overall Survival at 5 Years with Combined Immunotherapy for Advanced Melanoma

 


Systematic Review: Phototherapy for atopic eczema.

3 Dec, 2021 | 10:03h | UTC

Phototherapy for atopic eczema – Cochrane Library

Summary: What are the benefits and risks of visible light therapy for treating atopic eczema (also known as eczema or atopic dermatitis)? – Cochrane Library

 

Commentary on Twitter

 


Guideline on Cutaneous Angiosarcomas – Update 2021.

26 Nov, 2021 | 10:00h | UTC

S1-Guideline Cutaneous Angiosarcomas – Update 2021 – Journal of the German Society of Dermatology

 


AAP Clinical Report: Biologics for Asthma and Allergic Skin Diseases in Children.

19 Nov, 2021 | 10:34h | UTC

Biologics for Asthma and Allergic Skin Diseases in Children – Pediatrics

 


Systematic Review: Management of cutaneous immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors.

29 Oct, 2021 | 09:46h | UTC

Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Review – JAMA Oncology (free for a limited period)

 


Podcast: Atopic Dermatitis Pearls.

27 Oct, 2021 | 01:01h | UTC

Atopic Dermatitis Pearls – The Cribsiders

 


Guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery.

19 Oct, 2021 | 09:50h | UTC

S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery – Journal of the German Society of Dermatology

 


Review: Management of infectious emergencies for the inpatient dermatologist.

17 Oct, 2021 | 21:06h | UTC

Management of Infectious Emergencies for the Inpatient Dermatologist – Current Dermatology Reports (if this link is paywalled, try this one)

 


RCT: Laser treatment not better than sham treatment on symptom severity in women with postmenopausal vaginal symptoms.

13 Oct, 2021 | 01:30h | UTC

Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial – JAMA (free for a limited period)

News release: This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo – University of New South Wales

Editorial: Time for a “Pause” on the Use of Vaginal Laser (free for a limited period)

Author Interview: Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms

Commentary: Vagina lasering for postmenopausal women ‘may be placebo’ – The Guardian

 

Commentary on Twitter

 


Review: Life-threatening skin conditions presenting to critical care.

28 Sep, 2021 | 08:57h | UTC

Life-threatening skin conditions presenting to critical care – BJA Education

 


A guide to the treatment of cellulitis and other soft-tissue infections.

16 Sep, 2021 | 09:47h | UTC

A guide to the Tx of cellulitis and other soft-tissue infections – Journal of Family Practice

 


Viewpoint: Sentinel lymph node biopsy in cutaneous melanoma—where do we stand?

22 Aug, 2021 | 22:16h | UTC

Sentinel Lymph Node Biopsy in Cutaneous Melanoma—Where Do We Stand? – JAMA Dermatology (free for a limited period)

 


Guideline: Diagnosis and management of cutaneous lupus erythematosus – Classification, diagnosis, prevention, activity scores.

16 Aug, 2021 | 00:57h | UTC

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores – Journal of German Society of Dermatology

See also: S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics – Journal of German Society of Dermatology

 


German S3-Guideline on the treatment of Psoriasis vulgaris.

13 Aug, 2021 | 09:45h | UTC

German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations – Journal of the German Society of Dermatology

 


Guideline: Diagnosis and management of cutaneous lupus erythematosus – Therapy, risk factors and other special topics.

12 Aug, 2021 | 08:55h | UTC

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics – Journal of German Society of Dermatology

 


Brief review: Nails in systemic disease.

12 Aug, 2021 | 08:40h | UTC

Nails in systemic disease – Clinical Medicine Journal

 


Brief review: Immunobullous disease.

12 Aug, 2021 | 08:37h | UTC

Immunobullous disease – Clinical Medicine Journal

 


Stay Updated in Your Specialty

No spam, just news.